Response of chronic neuropathic pain syndromes to ketamine: a preliminary study
M Backonja, G Arndt, KA Gombar, B Check… - Pain, 1994 - Elsevier
Abstract
Hyperactivity of N-methyl-d-aspartate (NMDA) receptors may be one of the factors in the genesis of neuropathic pain. Ketamine is an NMDA-blocking agent widely used in human medicine. Ketamine (at 250 mcg/kg iv slow push) was administered to 6 patients for control …
Last updated: Jul 27, 2020